- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | BullFrog AI Holdings, Inc.: BullFrog AI Publishes Whitepaper on AI in Bioinformatics: Turning Complex Data into Actionable Insights | 2 | GlobeNewswire (USA) | ||
| 24.10. | BullFrog AI: Aktionäre stimmen für Kapitalerhöhung und Aktienzusammenlegung | 2 | Investing.com Deutsch | ||
| 24.10. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.10. | RedChip Companies, Inc.: BullFrog AI and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 337 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / October 24, 2025 / RedChip Companies will air interviews with BullFrog AI, Inc. (Nasdaq:BFRG) and Bimergen Energy Corp. (OCTQB:BESS) on the RedChip Small Stocks... ► Artikel lesen | |
| BULLFROG AI Aktie jetzt für 0€ handeln | |||||
| 10.10. | Bullfrog AI files to sell 5M shares of common stock for holders | 4 | Seeking Alpha | ||
| 10.10. | BullFrog AI Holdings, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 09.10. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 23.09. | Bullfrog AI ändert Satzung und wählt Direktoren auf Hauptversammlung | 1 | Investing.com Deutsch | ||
| 23.09. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.09. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 08.09. | BullFrog AI Holdings, Inc.: BullFrog AI's bfPREP and bfLEAP Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration | 7 | GlobeNewswire (USA) | ||
| 27.08. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 13.08. | BullFrog AI Holdings, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 22.07. | BullFrog AI Holdings, Inc.: Rethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug Development | 4 | GlobeNewswire (USA) | ||
| 18.07. | RedChip Companies, Inc.: Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 410 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / July 18, 2025 / RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and BullFrog AI, Inc. (Nasdaq:BFRG) on the RedChip Small... ► Artikel lesen | |
| 20.06. | BullFrog AI Holdings, Inc.: BullFrog AI's Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar | 3 | GlobeNewswire (USA) | ||
| 12.06. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.06. | BullFrog AI Holdings, Inc.: BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks to Global Biopharma Clients | 2 | GlobeNewswire (USA) | ||
| 11.04. | RedChip Companies, Inc.: Bullfrog AI and Connect Biopharma Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 435 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / April 11, 2025 / RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited (Nasdaq:CNTB) and on... ► Artikel lesen | |
| 27.12.24 | BullFrog AI Holdings, Inc.: BullFrog AI Issues Letter to Stockholders | 285 | GlobeNewswire (Europe) | GAITHERSBURG, Md., Dec. 27, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BB BIOTECH | 45,100 | 0,00 % | BB Biotech im Aufwind - Zinswende treibt Biotech-Rally an | US-Zinssenkung belebt den Biotech-Sektor. BB Biotech glänzt mit starkem Quartal, vier Exits und klarer Outperformance gegenüber dem Nasdaq Biotech Index. Seit der ersten Zinssenkung der US-Notenbank... ► Artikel lesen | |
| QIAGEN | 38,635 | +1,48 % | JEFFERIES stuft QIAGEN NV auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Qiagen mit einem Kursziel von 57 US-Dollar auf "Buy" belassen. Die Profitabilität dürfte 2026 zumindest stabil bleiben... ► Artikel lesen | |
| AMGEN | 289,55 | -2,54 % | Amgen's IMDELLTRA Gets Full FDA Approval For Extensive Stage Small Cell Lung Cancer | THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) announced that the U.S. Food and Drug Administration has granted full approval to IMDELLTRA (tarlatamab-dlle) for the treatment of adult patients with... ► Artikel lesen | |
| NOVAVAX | 5,633 | +2,33 % | Novavax bei Jefferies London: Strategischer Wandel hin zu Partnerschaften | ||
| STRYKER | 317,10 | +0,35 % | Stryker stock leads joint replacement robotics market, says Piper Sandler | ||
| ILLUMINA | 104,50 | +0,27 % | Pacific Biosciences: Mit Long-Read-Sequenzierung zum Angriff auf Illumina | ||
| CRISPR THERAPEUTICS | 45,400 | +3,18 % | Crispr Therapeutics gains amid takeover speculation | ||
| AAP IMPLANTATE | 1,360 | -4,23 % | EQS-NVR: aap Implantate AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Gesamtstimmrechtsmitteilung: aap Implantate AG
/ Veröffentlichung der Gesamtzahl der Stimmrechte
aap Implantate AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach §... ► Artikel lesen | |
| OCUGEN | 0,973 | -1,16 % | Ocugen Provides Business Update with Third Quarter 2025 Financial Results | Phase 2/3 OCU410ST GARDian3 pivotal confirmatory trial is progressing toward 1H 2027 Biologics License Application (BLA) filing with 50% enrollment completed to date European Medicines Agency (EMA)... ► Artikel lesen | |
| SANGAMO THERAPEUTICS | 0,370 | +8,54 % | Sangamo Therapeutics, Inc.: Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results | Held meeting with U.S. Food and Drug Administration (FDA) where, among other things, they reiterated October 2024 agreement to use estimated glomerular filtration rate (eGFR) slope as an endpoint... ► Artikel lesen | |
| INTELLIA THERAPEUTICS | 7,440 | +4,00 % | Should You Buy the Dip in Intellia Therapeutics Stock? | ||
| SCORPIUS | 0,072 | 0,00 % | Scorpius Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | ||
| TEMPUS AI | 63,50 | +5,83 % | How Did Tempus AI Power Its Move to Positive EBITDA in Q3? | ||
| DEFENCE THERAPEUTICS | 0,502 | -3,09 % | Defence Therapeutics Inc.: Defence Therapeutics to Build ADC Drug Delivery Powerhouse Using Its Proprietary Accum Technology | Montreal, Quebec--(Newsfile Corp. - November 19, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company pioneering next-generation... ► Artikel lesen | |
| EDITAS MEDICINE | 2,285 | +4,72 % | Editas Medicine, Inc.: Editas Medicine Nominates EDIT-401, an LDLR-Targeted Medicine, as Lead In Vivo Development Candidate | EDIT-401 achieved ~90% mean LDL-C reduction with single dose in non-human primates EDIT-401 on track for human proof-of-concept data by end of 2026 Strong cash position with operational runway into... ► Artikel lesen |
Das Unternehmen BULLFROG AI HOLDINGS INC kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,937 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLFROG AI HOLDINGS INC finden Sie auf Wallstreet Online.